Oct 05, 2022

Concomitant chemoradiotherapy is the usual treatment for locally advanced cervical cancer. Pelvic irradiation is usually advised for patients with negative para-aortic lymph nodes (PALNs). However, ow...

Oct 05, 2022

The phrases machine learning, deep learning, and artificial intelligence (AI) have entered practically every field of medicine. These approaches have advanced to the forefront of medical imaging resea...

Oct 05, 2022

When compared to standard chemotherapy, the first-line combination of pembrolizumab plus lenvatinib (PL) for patients with mismatch repair-proficient (pMMR) advanced endometrial cancer (aEC) from the ...

Oct 05, 2022

Myometrial invasion with a microcystic, elongated, fragmented (MELF) pattern is a unique histologic characteristic rarely seen in low-grade endometrial carcinomas (EC). Due to contradictory results an...

Oct 05, 2022

In this study, researchers aimed to evaluate the prognostic utility of combining tumor molecular subtype with computerized tomography (CT) imaging for surgical outcomes following primary cytoreductive...

Oct 05, 2022

As part of cancer treatment, it is advised that patients be screened for and given support for distress. This study aimed to assess distress levels, potential triggers, and adherence to psychosocial f...

Oct 05, 2022

Researchers’ goal was to use the cancer-work management conceptual framework to solicit ovarian cancer patients' perspectives on job demands, cancer demands, and workplace or cancer services and tec...

Oct 05, 2022

Most ovarian cancers in women over 30 arise from preexisting epithelial cells. When deciding how extensive surgical staging is needed, it is helpful to employ an intraoperative frozen section to diffe...

Oct 05, 2022

Researchers’ mission was to analyze the effect of an Enhanced Recovery After Surgery (ERAS) procedure on the rate of opioid prescription renewals and unplanned patient-provider contacts in the first...

Oct 05, 2022

The purpose of this research was to evaluate whether or not women who underwent superficial or deep inguinal lymph node dissections for suspected early-stage vulvar cancer had a higher rate of groin r...

Oct 05, 2022

Growing evidence shows a role for other genes that may disclose new clinical care options for hereditary uterine cancer (UC), which has historically been linked to pathogenic/likely pathogenic germlin...

Oct 04, 2022

High-grade serous ovarian cancer (HGSOC) is the most frequent subtype of ovarian cancer and is associated with high mortality rates. The surgical outcome is one of the most important prognostic variab...

Oct 04, 2022

Studies have shown that survivors of cervical cancer often have trouble sleeping. But there isn't a lot of data on hypnotics' effectiveness. Researchers looked for indicators of long-term hypnotic usa...

Oct 04, 2022

When it comes to uterine leiomyosarcoma (uLMS), the best adjuvant treatment has yet to be determined. Researchers assessed the frequency with which stage II and III uLMS had adjuvant chemotherapy and ...

Oct 04, 2022

Since the bulk of human epididymis protein 4 (HE4) studies was conducted in oncology facilities, it is uncertain how useful serum HE4 is in guiding referral decisions in patients with an ovarian tumor...

Oct 04, 2022

For the treatment of obvious early-stage endometrial cancer (EC), sentinel lymph node mapping (SNM) has become increasingly popular. Here, researchers examined how well 3 distinct methods of nodal ass...

Oct 04, 2022

Patients with epithelial ovarian cancer (EOC) are encouraged to have adjuvant chemotherapy administered no later than 42 days after surgery. This research aimed to determine whether or not postponing ...

Oct 04, 2022

Patients with recurrent ovarian cancer can evaluate the efficacy and safety of palliative chemotherapy by using the Measure of Ovarian Symptoms and Treatment (MOST) concerns; a validated patient-repor...

Oct 04, 2022

In the phase 2 multi-cohort KEYNOTE-158 study, pembrolizumab showed an objective response rate that was clinically significant in patients with advanced MSI-H/dMMR endometrial cancer who had had prior...

Oct 04, 2022

Patients with high-risk histology endometrial cancer (EC; grade 3 endometrioid adenocarcinoma, papillary serous carcinoma [PS], clear cell carcinoma [CC], and carcinosarcoma) were compared between min...